Glycomimetics for the inhibition and modulation of lectins

S Leusmann, P Ménová, E Shanin, A Titz… - Chemical Society …, 2023 - pubs.rsc.org
Carbohydrates are essential mediators of many processes in health and disease. They
regulate self-/non-self-discrimination, are key elements of cellular communication, cancer …

Is autophagy always a barrier to cisplatin therapy?

J Xu, DA Gewirtz - Biomolecules, 2022 - mdpi.com
Cisplatin has long been a first-line chemotherapeutic agent in the treatment of cancer,
largely for solid tumors. During the course of the past two decades, autophagy has been …

Galectins as pivotal components in oncogenesis and immune exclusion in human malignancies

NI Kapetanakis, P Busson - Frontiers in Immunology, 2023 - frontiersin.org
Galectins are galactoside-binding proteins, exerting numerous functions inside and outside
the cell, particularly conferring adaptation to stress factors. For most of them, aberrant …

[HTML][HTML] Galectins as modulators of receptor tyrosine kinases signaling in health and disease

N Porębska, M Poźniak, A Matynia, D Żukowska… - Cytokine & Growth …, 2021 - Elsevier
Receptor tyrosine kinases (RTKs) constitute a large group of cell surface proteins that
mediate communication of cells with extracellular environment. RTKs recognize external …

Inhibition of galectins in cancer: Biological challenges for their clinical application

DJ Laderach, D Compagno - Frontiers in Immunology, 2023 - frontiersin.org
Galectins play relevant roles in tumor development, progression and metastasis.
Accordingly, galectins are certainly enticing targets for medical intervention in cancer. To …

Toward understanding the mechanisms of malignant peripheral nerve sheath tumor development

T Mohamad, C Plante, JP Brosseau - International Journal of Molecular …, 2021 - mdpi.com
Malignant peripheral nerve sheath tumors (MPNSTs) originate from the neural crest lineage
and are associated with the neurofibromatosis type I syndrome. MPNST is an unmet clinical …

Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma

L Zhou, J Tian, K Wang, Y Ma, X Chen, H Luo… - Cancer …, 2024 - aacrjournals.org
Resistance to paclitaxel poses a major obstacle in esophageal squamous cell carcinoma
(ESCC) treatment. A better understanding of the mechanisms underlying paclitaxel …

Targeting galectins in T cell-based immunotherapy within tumor microenvironment

QY Jin, YS Li, XH Qiao, JW Yang, XL Guo - Life Sciences, 2021 - Elsevier
Over the past few years, tumor immunotherapy has emerged as an innovative tumor
treatment and owned incomparable advantages over other tumor therapy. With unique …

Galectin-1 ameliorates influenza A H1N1pdm09 virus-induced acute lung injury

J Bao, X Wang, S Liu, Q Zou, S Zheng, F Yu… - Frontiers in …, 2020 - frontiersin.org
Influenza remains one of the major epidemic diseases worldwide. Acute lung injury mainly
caused by excessive pro-inflammatory host immune responses leads to high mortality rates …

Galectin-1 and -3 in high amounts inhibit angiogenic properties of human retinal microvascular endothelial cells in vitro

A Hillenmayer, CM Wertheimer, A Geerlof, KH Eibl… - Plos one, 2022 - journals.plos.org
Purpose Galectin-1 and-3 are β-galactoside binding lectins with varying effects on
angiogenesis and apoptosis. Since in retinal pigment epithelial cells high amounts of human …